Author: Customer Service

Stairway to Seven mission tested and validated key Alpha Block II upgrades ahead of Flight 8LOMPOC, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Firefly Aerospace (Nasdaq: FLY), a market leading space and defense technology company, today announced the successful launch of its Alpha Flight 7 Stairway to Seven mission. Alpha lifted off from Firefly’s Space Launch Complex 2 at the Vandenberg Space Force Base at 5:50 pm PDT on March 11 before completing an orbital insertion and delivering a demonstrator payload for Lockheed Martin. Firefly’s Alpha rocket also performed a stage two engine relight and validated key Alpha Block II upgrades, including a new in-house avionics suite and enhanced thermal protection system, ahead of the full Block II configuration upgrade planned for Flight 8. “Alpha Flight 7 was flawlessly executed with all...

MALTA, N.Y., March 11, 2026 (GLOBE NEWSWIRE) — GlobalFoundries (Nasdaq: GFS) (GF) today announced the pricing of a secondary public offering of 20,000,000 ordinary shares to the public at a price to the public of $42.00 per share and $300 million of ordinary shares to be repurchased by GF, as described below. All of the shares in the offering are being offered by Mubadala Technology Investment Company (the “Selling Shareholder”). The Selling Shareholder is a wholly owned subsidiary of Mubadala Investment Company PJSC (which, together with its affiliates, is GF’s largest shareholder). The Selling Shareholder has also granted the underwriters a 30-day option to purchase up to an additional 3,000,000 of GF’s ordinary shares (equal to 15% of the initial ordinary shares being sold to the public) at the public offering price minus underwriting...

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the appointment of Teresa Montagut MD, PhD in the newly established position of Head of Clinical Development and Medical Affairs reporting to the Chief Medical Officer Dr. Eric Rose. In this role, Teresa will lead Mesoblast’s medical affairs organization, fostering clinical collaborations and spearheading investigator-initiated trials, enhancing clinical and medical communications, and engaging with healthcare professionals. She will play a critical role in unlocking the value of Mesoblast’s cell therapy programs in new pediatric and adult inflammatory conditions in partnership with investigators and key opinion leaders. Teresa brings extensive experience...

CALGARY, Alberta, March 11, 2026 (GLOBE NEWSWIRE) — Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has accepted the Company’s Notice of Intention to renew its normal course issuer bid (“NCIB”). The NCIB allows Pulse to purchase up to 2,758,077 common shares (representing 10 percent of the public float of 27,580,778 common shares as at March 5, 2026). All shares will be purchased through the facilities of the TSX and/or alternative Canadian trading platforms. All shares purchased under the normal course issuer bid will be cancelled. The duration of the normal course issuer bid will be from March 16, 2026, through March 15, 2027. As of March 5, 2026, the Company had 50,714,857 common shares outstanding. The Company’s purchase of shares during...

GEORGE TOWN, CAYMAN ISLANDS, March 11, 2026 (GLOBE NEWSWIRE) — Metals Acquisition Corp. II (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to commence trading on March 12, 2026 on The New York Stock Exchange (“NYSE”) under the ticker symbol “MTAL.U.” Each unit sold in the offering consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on NYSE under the symbols “MTAL” and “MTAL WS,” respectively. The...

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC, March 11, 2026 (GLOBE NEWSWIRE) — Fobi AI Inc. (TSXV:FOBI) (Pink: FOBIF) (the “Company” or “Fobi“), an industry leader in harnessing AI and data intelligence to enable digital transformation, advises that its previously announced non-brokered private placement financing (“Offering”) has been granted an extension to close on or before March 19, 2026, or such other date or dates as may be determined by Fobi and acceptable to the TSXV. The Offering was first announced on December 12, 2025, with closing of the first two tranches of the Offering announced on January 23, 2026, and February 4, 2026, respectively.  The Company intends to use the net proceeds of the Offering for sales and marketing, product...